The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.
Open accessAbstract
The role of CD4+ and CD8+ T lymphocytes in terminating respiratory syncytial virus (RSV) replication, causing disease, and protecting from reinfection was investigated using a BALB/c mouse model in which CD4+ or CD8+ lymphocytes or both were depleted by injections of Mab directed against the respective mouse lymphocyte determinants. Kinetics of RSV replication, illness, and pathology were assessed after primary infection and rechallenge. Both CD4+ and CD8+ lymphocyte subsets were involved in terminating RSV replication after primary infection. When both T lymphocyte subsets were depleted RSV replication was markedly prolonged, yet no illness was evident, suggesting that host immune response rather than viral cytocidal effect was the primary determinant of disease in mice. Both CD4+ and CD8+ lymphocytes contributed to illness, although CD8+ lymphocytes appeared to play the dominant role in this particular system. Analysis of histological responses suggested that CD4+ lymphocytes were required for the appearance of peribronchovascular lymphocytic aggregates seen in normal mice after rechallenge, and that the presence of alveolar lymphocytes was correlated with illness. It is postulated that antibody is an illness-sparing mechanism for protecting mice from RSV infection, and that T lymphocytes are an important determinant of illness. Further delineation of RSV-induced immunopathogenesis in primary infection and reinfection will provide important information for the development of vaccine strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dialynas, D. P., Quan, Z. S., Wall, K. A., Pierres, A., Quintáns, J., Loken, M. R., Pierres, M., & Fitch, F. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.5.2445 · Cited by 1,273
Dialynas, D. P., Wilde, D. B., Marrack, P., Pierres, A., Wall, K. A., Havran, W., Otten, G., Loken, M. R., Pierres, M., Kappler, J., et al. (1983) · Immunological Reviews · doi:10.1111/j.1600-065x.1983.tb01083.x · Cited by 1,014
Sarmiento, M., Glasebrook, A. L., & Fitch, F. W. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.6.2665 · Cited by 802
Cannon, M. J., Openshaw, P. J., & Askonas, B. A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.3.1163 · Cited by 459
Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.
Wofsy, D., & Seaman, W. E. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.2.378 · Cited by 458
Primary respiratory syncytial virus infection in mice
Graham, B. S., Perkins, M. D., Wright, P. F., & Karzon, D. T. (1988) · Journal of Medical Virology · doi:10.1002/jmv.1890260207 · Cited by 393
Self-citationMonoclonal antibodies to promote marrow engraftment and tissue graft tolerance
Cobbold, S. P., Martin, G., Qin, S., & Waldmann, H. (1986) · Nature · doi:10.1038/323164a0 · Cited by 335
Fishaut, M., Tubergen, D., & McIntosh, K. (1980) · The Journal of Pediatrics · doi:10.1016/s0022-3476(80)80799-2 · Cited by 238
Functional analysis of T lymphocyte subsets in antiviral host defense.
Leist, T. P., Cobbold, S. P., Waldmann, H., Aguet, M., & Zinkernagel, R. M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.7.2278 · Cited by 233
Moskophidis, D., Cobbold, S. P., Waldmann, H., & Lehmann-Grube, F. (1987) · Journal of Virology · doi:10.1128/jvi.61.6.1867-1874.1987 · Cited by 186
Cited by
Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology
Tregoning, J. S., & Schwarze, J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00032-09 · Cited by 747
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
Respiratory Syncytial Virus—A Comprehensive Review
Borchers, A. T., Chang, C., Gershwin, M. E., & Gershwin, L. J. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8368-9 · Cited by 645
Respiratory syncytial virus infection
Simoes, E. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)80040-3 · Cited by 603
T cell-mediated immune response to respiratory coronaviruses
Channappanavar, R., Zhao, J., & Perlman, S. (2014) · Immunologic Research · doi:10.1007/s12026-014-8534-z · Cited by 512
“Furthermore, it will be interesting to know whether MHV-1-mediated lung pathology in A/J and C3H/ HeJ mice is due to an imbalance of Th1, Th2 and/or Th17 cell responses as shown in other respiratory virus infections such as RSV [85] [86] [87] .”
BackgroundThe histopathology of fatal untreated human respiratory syncytial virus infection
Johnson, J. E., Gonzales, R. A., Olson, S. J., Wright, P. F., & Graham, B. S. (2007) · Modern Pathology · doi:10.1038/modpathol.3800725 · Cited by 501
Self-citationDelgado, M. F., Coviello, S., Monsalvo, A. C., Melendi, G. A., Hernandez, J. Z., Batalle, J. P., Diaz, L., Trento, A., Chang, H.-Y., Mitzner, W., et al. (2009) · Nature Medicine · doi:10.1038/nm.1894 · Cited by 500
Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis
Collins, P. L., & Graham, B. S. (2008) · Journal of Virology · doi:10.1128/jvi.01625-07 · Cited by 486
Self-citationNewton, A. H., Cardani, A., & Braciale, T. J. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0558-0 · Cited by 476
No one is naive: the significance of heterologous T-cell immunity
Welsh, R. M., & Selin, L. K. (2002) · Nature Reviews Immunology · doi:10.1038/nri820 · Cited by 463
Collins, P. L., & Melero, J. A. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.020 · Cited by 455
Respiratory Syncytial Virus Infection in Adults
Falsey, A. R., & Walsh, E. E. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.371 · Cited by 438
Welliver, T. P., Garofalo, R. P., Hosakote, Y., Hintz, K. H., Avendano, L., Sanchez, K., Velozo, L., Jafri, H., Chavez‐Bueno, S., Ogra, P. L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/512615 · Cited by 425
Sex Differences in Pediatric Infectious Diseases
Muenchhoff, M., & Goulder, P. J. R. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu232 · Cited by 406
The CD8 T Cell Response to Respiratory Virus Infections
Schmidt, M. E., & Varga, S. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00678 · Cited by 371
“org April 2018 | Volume 9 | Article 678 Accordingly, RSV infection of mice depleted of CD8 T cells resulted in significantly increased lung viral titers at day 7 post-infection, although the virus was ultimately cleared by day 11 (26).”
BackgroundConnors, M., Giese, N. A., Kulkarni, A. B., Firestone, C. Y., Morse, H. C., & Murphy, B. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5321-5325.1994 · Cited by 348
Schwarze, J., Hamelmann, E., Bradley, K. L., Takeda, K., & Gelfand, E. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119516 · Cited by 328
Distinct types of lung disease caused by functional subsets of antiviral T cells.
Alwan, W. H., Kozlowska, W. J., & Openshaw, P. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.81 · Cited by 316
Wright, P. F., Karron, R. A., Belshe, R. B., Thompson, J., Crowe, Jr., Boyce, T. G., Halburnt, L. L., Reed, G. W., Whitehead, S. S., Anderson, E. L., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315859 · Cited by 307
Self-citationJozwik, A., Habibi, M. S., Paras, A., Zhu, J., Guvenel, A., Dhariwal, J., Almond, M., Wong, E. H. C., Sykes, A., Maybeno, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10224 · Cited by 297
Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection
Openshaw, P. J. M., & Tregoning, J. S. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.541-555.2005 · Cited by 292
Selin, L. K., Varga, S. M., Wong, I. C., & Welsh, R. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1705 · Cited by 273
Olszewska-Pazdrak, B., Casola, A., Saito, T., Alam, R., Crowe, S. E., Mei, F., Ogra, P. L., & Garofalo, R. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4756-4764.1998 · Cited by 269
Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment
Domachowske, J. B., & Rosenberg, H. F. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.298 · Cited by 260
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF
Duangchinda, T., Dejnirattisai, W., Vasanawathana, S., Limpitikul, W., Tangthawornchaikul, N., Malasit, P., Mongkolsapaya, J., & Screaton, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010867107 · Cited by 255
Graham, B. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00972.x · Cited by 239
Self-citationBondue, B., Vosters, O., de Nadai, P., Glineur, S., De Henau, O., Luangsay, S., Van Gool, F., Communi, D., De Vuyst, P., Desmecht, D., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002358 · Cited by 92
“Following an early and non-specific inflammatory response characterized by the recruitment of neutrophils and cytotoxic natural killer cells [9–10], a delayed adaptive immune response leads, 7 to 10 days after infection, to an important influx of CD8 cytotoxic T cells in the lung, and the production of RSVor PVM-speci…”
Respiratory syncytial virus vaccine development
Crowe, J. E. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00287-0 · Cited by 70
Metadata
- Authors
- Graham, B. S., Bunton, L. A., Wright, P. F., & Karzon, D. T.
- Venue
- Journal of Clinical Investigation
- Published
- 1991-09-01
- Volume
- 88
- Issue
- 3
- Pages
- 1026-1033
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2113821008
- Cited by
- 502
- References
- 26
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.